retatrutide clinical trials weight loss trial Retatrutide is getting a lot of attention, and for good reason ESC 2024: Retatrutide improves lipid
Description
Renal impairment GLP-1 RAs are generally safe in patients with CKD and have demonstrated nephroprotective effects in the FLOW trial, where semaglutide significantly reduced the composite renal endpoint (hospitalization for acute kidney injury, sustained 50% decline in estimated glomerular filtration rate (eGFR), end-stage kidney disease, or renal death) in patients with type 2 diabetes and CKD [15]
My doctor actually pulled up my previous results to double-check
Your prescription refills automatically each month unless you pause or canceland PlexusDx never charges membership fees or requires insurance
If you are working with compounded semaglutide in lyophilized form, you also need bacteriostatic water for reconstitution
If you want to understand why that matters, learn how to prevent muscle loss on GLP-1
